10x Genomics
TXG
$14.00
Share price
-4.37%
Change (1 day)
-31.07%
Change (1 year)
Categories
10x Genomics (TXG) - Total debt
Total debt on the balance sheet as of March 2025 : $80.07 Million USD
According to 10x Genomics 's latest financial reports the company's total debt is $80.07 Million USD. A company’s total debt is the sum of all current and non-current debts.
10x Genomics - Total debt on balance sheet (from 2018 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $82.61 M | -13.38% |
| 2023-12-31 | $95.37 M | 0.2% |
| 2022-12-31 | $95.17 M | 16.1% |
| 2021-12-31 | $81.97 M | 30.17% |
| 2020-12-31 | $62.97 M | 111.91% |
| 2019-12-31 | $29.71 M | 0.14% |
| 2018-12-31 | $29.67 M | 181.05% |
| 2017-12-31 | $10.55 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | $0.69 B | 770.11% | Jersey |
 Novavax NVAX | $0.22 B | 185.56% | 🇺🇸 USA |
 Organovo ONVO | $0.94 M | -98.82% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $47.82 M | -40.28% | 🇬🇧 UK |